Global Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

According to APO Research, The global Veterinary Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.

Veterinary Vaccine segment by Company

Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
BioTestLab
RVSRI
Medion
Veterinary Vaccine segment by Type

Live Attenuated Vaccines
Inactivated Vaccines
Others
Veterinary Vaccine segment by Application

Livestock
Swine
Chicken
Dog & Cat
Others
Veterinary Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Veterinary Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Veterinary Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Veterinary Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Veterinary Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Veterinary Vaccine Market Dynamics
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 Veterinary Vaccine Market by Manufacturers
3.1 Global Veterinary Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Veterinary Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Veterinary Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Veterinary Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Veterinary Vaccine Manufacturers, Product Type & Application
3.7 Global Veterinary Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Veterinary Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier 3
4 Veterinary Vaccine Market by Type
4.1 Veterinary Vaccine Type Introduction
4.1.1 Live Attenuated Vaccines
4.1.2 Inactivated Vaccines
4.1.3 Others
4.2 Global Veterinary Vaccine Sales by Type
4.2.1 Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Sales by Type (2019-2030)
4.2.3 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Veterinary Vaccine Revenue by Type
4.3.1 Global Veterinary Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Revenue by Type (2019-2030)
4.3.3 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
5 Veterinary Vaccine Market by Application
5.1 Veterinary Vaccine Application Introduction
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Sales by Application
5.2.1 Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Veterinary Vaccine Sales by Application (2019-2030)
5.2.3 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Veterinary Vaccine Revenue by Application
5.3.1 Global Veterinary Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Veterinary Vaccine Revenue by Application (2019-2030)
5.3.3 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
6 Global Veterinary Vaccine Sales by Region
6.1 Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Veterinary Vaccine Sales by Region (2019-2030)
6.2.1 Global Veterinary Vaccine Sales by Region (2019-2024)
6.2.2 Global Veterinary Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Veterinary Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Veterinary Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Veterinary Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Veterinary Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Veterinary Vaccine Revenue by Region
7.1 Global Veterinary Vaccine Revenue by Region
7.1.1 Global Veterinary Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Veterinary Vaccine Revenue by Region (2019-2024)
7.1.3 Global Veterinary Vaccine Revenue by Region (2025-2030)
7.1.4 Global Veterinary Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Veterinary Vaccine Revenue (2019-2030)
7.2.2 North America Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Veterinary Vaccine Revenue (2019-2030)
7.3.2 Europe Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Veterinary Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Veterinary Vaccine Revenue (2019-2030)
7.5.2 LAMEA Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Veterinary Vaccine Product Portfolio
8.1.5 Merck Recent Developments
8.2 Zoetis
8.2.1 Zoetis Comapny Information
8.2.2 Zoetis Business Overview
8.2.3 Zoetis Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Zoetis Veterinary Vaccine Product Portfolio
8.2.5 Zoetis Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Ceva
8.4.1 Ceva Comapny Information
8.4.2 Ceva Business Overview
8.4.3 Ceva Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Ceva Veterinary Vaccine Product Portfolio
8.4.5 Ceva Recent Developments
8.5 CAHIC
8.5.1 CAHIC Comapny Information
8.5.2 CAHIC Business Overview
8.5.3 CAHIC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 CAHIC Veterinary Vaccine Product Portfolio
8.5.5 CAHIC Recent Developments
8.6 HVRI
8.6.1 HVRI Comapny Information
8.6.2 HVRI Business Overview
8.6.3 HVRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 HVRI Veterinary Vaccine Product Portfolio
8.6.5 HVRI Recent Developments
8.7 Ringpu Biology
8.7.1 Ringpu Biology Comapny Information
8.7.2 Ringpu Biology Business Overview
8.7.3 Ringpu Biology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
8.7.5 Ringpu Biology Recent Developments
8.8 Yebio
8.8.1 Yebio Comapny Information
8.8.2 Yebio Business Overview
8.8.3 Yebio Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Yebio Veterinary Vaccine Product Portfolio
8.8.5 Yebio Recent Developments
8.9 DHN
8.9.1 DHN Comapny Information
8.9.2 DHN Business Overview
8.9.3 DHN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 DHN Veterinary Vaccine Product Portfolio
8.9.5 DHN Recent Developments
8.10 WINSUN
8.10.1 WINSUN Comapny Information
8.10.2 WINSUN Business Overview
8.10.3 WINSUN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 WINSUN Veterinary Vaccine Product Portfolio
8.10.5 WINSUN Recent Developments
8.11 Elanco
8.11.1 Elanco Comapny Information
8.11.2 Elanco Business Overview
8.11.3 Elanco Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Elanco Veterinary Vaccine Product Portfolio
8.11.5 Elanco Recent Developments
8.12 Virbac
8.12.1 Virbac Comapny Information
8.12.2 Virbac Business Overview
8.12.3 Virbac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Virbac Veterinary Vaccine Product Portfolio
8.12.5 Virbac Recent Developments
8.13 Jinyu Bio-Technology
8.13.1 Jinyu Bio-Technology Comapny Information
8.13.2 Jinyu Bio-Technology Business Overview
8.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
8.13.5 Jinyu Bio-Technology Recent Developments
8.14 ChengDu Tecbond
8.14.1 ChengDu Tecbond Comapny Information
8.14.2 ChengDu Tecbond Business Overview
8.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
8.14.5 ChengDu Tecbond Recent Developments
8.15 CAVAC
8.15.1 CAVAC Comapny Information
8.15.2 CAVAC Business Overview
8.15.3 CAVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 CAVAC Veterinary Vaccine Product Portfolio
8.15.5 CAVAC Recent Developments
8.16 Kyoto Biken Laboratories
8.16.1 Kyoto Biken Laboratories Comapny Information
8.16.2 Kyoto Biken Laboratories Business Overview
8.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
8.16.5 Kyoto Biken Laboratories Recent Developments
8.17 FATRO
8.17.1 FATRO Comapny Information
8.17.2 FATRO Business Overview
8.17.3 FATRO Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 FATRO Veterinary Vaccine Product Portfolio
8.17.5 FATRO Recent Developments
8.18 Vaksindo
8.18.1 Vaksindo Comapny Information
8.18.2 Vaksindo Business Overview
8.18.3 Vaksindo Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Vaksindo Veterinary Vaccine Product Portfolio
8.18.5 Vaksindo Recent Developments
8.19 Bio-Labs
8.19.1 Bio-Labs Comapny Information
8.19.2 Bio-Labs Business Overview
8.19.3 Bio-Labs Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
8.19.5 Bio-Labs Recent Developments
8.20 Avimex Animal Health
8.20.1 Avimex Animal Health Comapny Information
8.20.2 Avimex Animal Health Business Overview
8.20.3 Avimex Animal Health Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
8.20.5 Avimex Animal Health Recent Developments
8.21 MEVAC
8.21.1 MEVAC Comapny Information
8.21.2 MEVAC Business Overview
8.21.3 MEVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.21.4 MEVAC Veterinary Vaccine Product Portfolio
8.21.5 MEVAC Recent Developments
8.22 Biovac
8.22.1 Biovac Comapny Information
8.22.2 Biovac Business Overview
8.22.3 Biovac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.22.4 Biovac Veterinary Vaccine Product Portfolio
8.22.5 Biovac Recent Developments
8.23 Atafen
8.23.1 Atafen Comapny Information
8.23.2 Atafen Business Overview
8.23.3 Atafen Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.23.4 Atafen Veterinary Vaccine Product Portfolio
8.23.5 Atafen Recent Developments
8.24 Dyntec
8.24.1 Dyntec Comapny Information
8.24.2 Dyntec Business Overview
8.24.3 Dyntec Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.24.4 Dyntec Veterinary Vaccine Product Portfolio
8.24.5 Dyntec Recent Developments
8.25 BioTestLab
8.25.1 BioTestLab Comapny Information
8.25.2 BioTestLab Business Overview
8.25.3 BioTestLab Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.25.4 BioTestLab Veterinary Vaccine Product Portfolio
8.25.5 BioTestLab Recent Developments
8.26 RVSRI
8.26.1 RVSRI Comapny Information
8.26.2 RVSRI Business Overview
8.26.3 RVSRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.26.4 RVSRI Veterinary Vaccine Product Portfolio
8.26.5 RVSRI Recent Developments
8.27 Medion
8.27.1 Medion Comapny Information
8.27.2 Medion Business Overview
8.27.3 Medion Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.27.4 Medion Veterinary Vaccine Product Portfolio
8.27.5 Medion Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Veterinary Vaccine Value Chain Analysis
9.1.1 Veterinary Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Veterinary Vaccine Production Mode & Process
9.2 Veterinary Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Veterinary Vaccine Distributors
9.2.3 Veterinary Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings